Recently, treatment of MDA-MB-231, aggressive breast cancer cells, with a monoclonal antibody specific for ROR1 inhibited cancer cell migration and invasion in vitro and tumor metastasis in vivo, indicating that ROR1 may suppress breast cancer progression and metastasis via regulating epithelial-mesenchymal transition (EMT) [12]. Here, ROR1 is linked to breast carcinoma.